Related Experiment Video
Updated: Oct 11, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Design and Rationale for a Real-World Prospective, Multicenter Registry of Myocardial Revascularization Failure and
Pablo Salinas1, Jean Paul Vilchez-Tschischke2, Francisco Noriega1
1Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
The REVASEC Registry tracks patients with myocardial revascularization failure (MRF) and secondary revascularization (SR). It aims to understand MRF causes, treatments, and patient outcomes in current practice.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Research
Background:
- Myocardial revascularization failure (MRF) and the need for secondary revascularization (SR) are significant clinical challenges.
- Contemporary data on the characteristics, management, and outcomes of patients undergoing repeat revascularization are limited.
Purpose of the Study:
- To investigate key aspects of myocardial revascularization failure (MRF) and secondary revascularization (SR) in current practice.
- To describe patient characteristics, rates and mechanisms of MRF, management strategies, and prognosis in patients referred for repeat angiography.
Main Methods:
- The REVASEC (Registry of Secondary Revascularization) is a prospective, multicenter registry.
- It includes patients with prior revascularization referred for coronary angiography due to suspected MRF.
- Data includes patient characteristics, MRF mechanisms (stent/graft failure, disease progression), management (medical therapy, SR), and 1-year patient-oriented composite endpoints.
Main Results:
- The REVASEC Registry will provide updated data on patient characteristics, treatment patterns, and 1-year outcomes.
- Analysis will focus on the rates and mechanisms of MRF and the effectiveness of different management strategies.
- Prognosis will be assessed based on identified causative mechanisms of MRF.
Conclusions:
- The REVASEC Registry will offer valuable insights into contemporary clinical practice regarding MRF and SR.
- Findings will inform clinical decision-making and potentially improve patient outcomes.
- Updated data on MRF mechanisms and SR effectiveness are crucial for advancing cardiovascular care.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy

